Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic MelanomaPaul B. Chapman, John M. Kirkwood, Alicia N. Destro et al.|Journal of Clinical Oncology|1999Cited by 763
Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens.Anthony P. Albino, Lloyd J. Old, Kenneth O. Lloyd et al.|The Journal of Experimental Medicine|1981Cited by 211